Race Oncology - Cashflow Forecast to December 2024, page-20

I can genuinely see why some people will be frustrated at the SP action. Unfortunately this is partly a result of negligent money flow into the sector atm apart from some niche shares (cu6 etc) that are in the clinic and expected results shortly. The market knows not a lot will happen before the appropriate approvals are received untill later in the year. But once we are in the clinic and the first update comes in that is when I’m expecting some serious money to start flowing in from funds etc. Hard as it is patience is still the key, at least we have a battle plan unlike some other companies I dare not mention